SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Ynto S. de Boer, Nicole M.F. van Gerven, Antonie Zwiers, Bart J. Verwer, Bart van Hoek, Karel J. van Erpecum, Ulrich Beuers, Henk R. van Buuren, Joost P.H. Drenth, Jannie W. den Ouden, Robert C. Verdonk, Ger H. Koek, Johannes T. Brouwer, Maureen M.J. Guichelaar, Jan M. Vrolijk, Georg Kraal, Chris J.J. Mulder, Carin M.J. van Nieuwkerk, Janett Fischer, Thomas Berg, Felix Stickel, Christoph Sarrazin, Christoph Schramm, Ansgar W. Lohse, Christina Weiler-Normann, Markus M. Lerch, Matthias Nauck, Henry Völzke, Georg Homuth, Elisabeth Bloemena, Hein W. Verspaget, Vinod Kumar, Alexandra Zhernakova, Cisca Wijmenga, Lude Franke, Gerd Bouma, Genome-Wide Association Study Identifies Variants Associated With Autoimmune Hepatitis Type 1, Gastroenterology, 2014, 147, 2, 443

    CrossRef

  2. 2
    Urs Christen, Edith Hintermann, Pathogen Infection as a Possible Cause for Autoimmune Hepatitis, International Reviews of Immunology, 2014, 33, 4, 296

    CrossRef

  3. 3
    A. J. Czaja, Review article: permanent drug withdrawal is desirable and achievable for autoimmune hepatitis, Alimentary Pharmacology & Therapeutics, 2014, 39, 10
  4. 4
    A. J. Czaja, Review article: the prevention and reversal of hepatic fibrosis in autoimmune hepatitis, Alimentary Pharmacology & Therapeutics, 2014, 39, 4
  5. 5
    J. Chen, G. D. Eslick, M. Weltman, Systematic review with meta-analysis: clinical manifestations and management of autoimmune hepatitis in the elderly, Alimentary Pharmacology & Therapeutics, 2014, 39, 2
  6. 6
    Albert J. Czaja, Acute and Acute Severe (Fulminant) Autoimmune Hepatitis, Digestive Diseases and Sciences, 2013, 58, 4, 897

    CrossRef

  7. 7
    Cumali Efe, Ersan Ozaslan, Staffan Wahlin, Tugrul Purnak, Luigi Muratori, Chiara Quarneti, Osman Yüksel, Paolo Muratori, Antibodies to soluble liver antigen in patients with various liver diseases: A multicentre study, Liver International, 2013, 33, 2
  8. 8
    Albert J Czaja, Autoimmune hepatitis in diverse ethnic populations and geographical regions, Expert Review of Gastroenterology & Hepatology, 2013, 7, 4, 365

    CrossRef

  9. 9
    Nicole M. F. Gerven, Ynto S. Boer, Antonie Zwiers, Bart Hoek, Karel J. Erpecum, Ulrich Beuers, Henk R. Buuren, Joost P. H. Drenth, Jannie W. den Ouden, Robert C. Verdonk, Ger H. Koek, Johannes T. Brouwer, Maureen M. J. Guichelaar, Jan M. Vrolijk, G. Kraal, Chris J. J. Mulder, Carin. M. J. Nieuwkerk, Gerd Bouma, Cytotoxic T Lymphocyte Antigen–4 +49A/G polymorphism does not affect susceptibility to autoimmune hepatitis, Liver International, 2013, 33, 7
  10. 10
    Albert J. Czaja, Management of Recalcitrant Autoimmune Hepatitis, Current Hepatitis Reports, 2013, 12, 1, 66

    CrossRef

  11. 11
    Ryutaro Maruoka, Nobuhiro Aoki, Masahiro Kido, Satoru Iwamoto, Hisayo Nishiura, Aki Ikeda, Tsutomu Chiba, Norihiko Watanabe, Splenectomy Prolongs the Effects of Corticosteroids in Mouse Models of Autoimmune Hepatitis, Gastroenterology, 2013, 145, 1, 209

    CrossRef

  12. 12
    Alessandro Paiardini, Stefano Pascarella, Structural mimicry between SLA/LP and Rickettsia surface antigens as a driver of autoimmune hepatitis: insights from an in silico study, Theoretical Biology and Medical Modelling, 2013, 10, 1, 25

    CrossRef

  13. 13
    Kelly Hudspeth, Elena Pontarini, Paolo Tentorio, Matteo Cimino, Matteo Donadon, Guido Torzilli, Enrico Lugli, Silvia Della Bella, M. Eric Gershwin, Domenico Mavilio, The role of natural killer cells in autoimmune liver disease: A comprehensive review, Journal of Autoimmunity, 2013, 46, 55

    CrossRef

  14. 14
    Albert J. Czaja, Advances in the Current Treatment of Autoimmune Hepatitis, Digestive Diseases and Sciences, 2012, 57, 8, 1996

    CrossRef

  15. 15
    Albert J. Czaja, Diagnosis, Pathogenesis, and Treatment of Autoimmune Hepatitis After Liver Transplantation, Digestive Diseases and Sciences, 2012, 57, 9, 2248

    CrossRef

  16. 16
    Rodrigo Liberal, Diego Vergani, Effect of ethnicity on the clinical presentation and outcome of autoimmune hepatitis, Expert Review of Gastroenterology & Hepatology, 2012, 6, 3, 267

    CrossRef

  17. 17
    Kaname Yoshizawa, Akihiro Matsumoto, Tetsuya Ichijo, Takeji Umemura, Satoru Joshita, Michiharu Komatsu, Naoki Tanaka, Eiji Tanaka, Masao Ota, Yoshihiko Katsuyama, Kendo Kiyosawa, Masanori Abe, Morikazu Onji, Long-term outcome of Japanese patients with type 1 autoimmune hepatitis, Hepatology, 2012, 56, 2
  18. 18
    Aldo J. Montano-Loza, Zakera Shums, Gary L. Norman, Albert J. Czaja, Prognostic implications of antibodies to Ro/SSA and soluble liver antigen in type 1 autoimmune hepatitis, Liver International, 2012, 32, 1
  19. 19
    Shashi Amur, Ameeta Parekh, Padmaja Mummaneni, Sex differences and genomics in autoimmune diseases, Journal of Autoimmunity, 2012, 38, 2-3, J254

    CrossRef

  20. 20
    Robert John Wong, Robert Gish, Todd Frederick, Natalie Bzowej, Catherine Frenette, The Impact of Race/Ethnicity on the Clinical Epidemiology of Autoimmune Hepatitis, Journal of Clinical Gastroenterology, 2012, 46, 2, 155

    CrossRef

  21. 21
    Dimitrios P. Bogdanos, Daniel S. Smyk, Eirini I. Rigopoulou, Maria G. Mytilinaiou, Michael A. Heneghan, Carlo Selmi, M. Eric Gershwin, Twin studies in autoimmune disease: Genetics, gender and environment, Journal of Autoimmunity, 2012, 38, 2-3, J156

    CrossRef

  22. 22
    Ansgar W. Lohse, Giorgina Mieli-Vergani, Autoimmune hepatitis, Journal of Hepatology, 2011, 55, 1, 171

    CrossRef

  23. 23
    Albert J. Czaja, Autoimmune hepatitis in special patient populations, Best Practice & Research Clinical Gastroenterology, 2011, 25, 6, 689

    CrossRef

  24. 24
    Albert J. Czaja, Comparability of Probable and Definite Autoimmune Hepatitis by International Diagnostic Scoring Criteria, Gastroenterology, 2011, 140, 5, 1472

    CrossRef

  25. 25
    Albert J. Czaja, Cryptogenic Chronic Hepatitis and Its Changing Guise in Adults, Digestive Diseases and Sciences, 2011, 56, 12, 3421

    CrossRef

  26. 26
    Jawad A. Ilyas, Christine A. O’Mahony, John M. Vierling, Liver transplantation in autoimmune liver diseases, Best Practice & Research Clinical Gastroenterology, 2011, 25, 6, 765

    CrossRef

  27. 27
    Ian R. Mackay, Systemic Lupus Erythematosus, 2011,

    CrossRef

  28. 28
    Albert J. Czaja, Michael P. Manns, Advances in the Diagnosis, Pathogenesis, and Management of Autoimmune Hepatitis, Gastroenterology, 2010, 139, 1, 58

    CrossRef

  29. 29
    Albert J Czaja, Animal models of autoimmune hepatitis, Expert Review of Gastroenterology & Hepatology, 2010, 4, 4, 429

    CrossRef

  30. 30
    Albert J. Czaja, Autoantibodies as Prognostic Markers in Autoimmune Liver Disease, Digestive Diseases and Sciences, 2010, 55, 8, 2144

    CrossRef

  31. 31
    Albert J. Czaja, Late Relapse of Type 1 Autoimmune Hepatitis After Corticosteroid Withdrawal, Digestive Diseases and Sciences, 2010, 55, 6, 1761

    CrossRef

  32. 32
    Albert J. Czaja, Sleisenger and Fordtran's Gastrointestinal and Liver Disease, 2010,

    CrossRef

  33. 33
    Albert J Czaja, Current and future treatments of autoimmune hepatitis, Expert Review of Gastroenterology & Hepatology, 2009, 3, 3, 269

    CrossRef

  34. 34
    Andrea Cassinotti, Sarah Birindelli, Mario Clerici, Daria Trabattoni, Marco Lazzaroni, Sandro Ardizzone, Riccardo Colombo, Edoardo Rossi, Gabriele Bianchi Porro, HLA and Autoimmune Digestive Disease: A Clinically Oriented Review for Gastroenterologists, The American Journal of Gastroenterology, 2009, 104, 1, 195

    CrossRef

  35. 35
    Carolina Duarte-Rey, Aryce L. Pardo, Yolima Rodríguez-Velosa, Ruben D. Mantilla, Juan-Manuel Anaya, Adriana Rojas-Villarraga, HLA class II association with autoimmune hepatitis in Latin America: A meta-analysis, Autoimmunity Reviews, 2009, 8, 4, 325

    CrossRef

  36. 36
    A.J. DEMETRIS, JAMES M. CRAWFORD, MARTA IDA MINERVINI, MIKE NALESNIK, ERIN OCHOA, PARMJEET RANDHAWA, EIZABURO SASATOMI, TONG WU, Surgical Pathology of the GI Tract, Liver, Biliary Tract, and Pancreas, 2009,

    CrossRef

  37. 37
    Takeji Umemura, Masao Ota, Kaname Yoshizawa, Yoshihiko Katsuyama, Tetsuya Ichijo, Eiji Tanaka, Kendo Kiyosawa, Association of cytotoxic T-lymphocyte antigen 4 gene polymorphisms with type 1 autoimmune hepatitis in Japanese, Hepatology Research, 2008, 38, 7
  38. 38
    Paolo Muratori, Alessandro Granito, Georgios Pappas, Luigi Muratori, Marco Lenzi, Francesco B. Bianchi, Autoimmune liver disease 2007, Molecular Aspects of Medicine, 2008, 29, 1-2, 96

    CrossRef

  39. 39
    Albert J Czaja, Clinical Features, Differential Diagnosis and Treatment of Autoimmune Hepatitis in the Elderly, Drugs & Aging, 2008, 25, 3, 219

    CrossRef

  40. 40
    Suk Seo, Raphael Toutounjian, Andrew Conrad, Larry Blatt, Myron J Tong, Favorable outcomes of autoimmune hepatitis in a community clinic setting, Journal of Gastroenterology and Hepatology, 2008, 23, 9
  41. 41
    Aldo J. Montano-Loza, Herschel A. Carpenter, Albert J. Czaja, Frequency, Behavior, and Prognostic Implications of Antimitochondrial Antibodies in Type 1 Autoimmune Hepatitis, Journal of Clinical Gastroenterology, 2008, 42, 9, 1047

    CrossRef

  42. 42
    Albert J. Czaja, Genetic Factors Affecting the Occurrence, Clinical Phenotype, and Outcome of Autoimmune Hepatitis, Clinical Gastroenterology and Hepatology, 2008, 6, 4, 379

    CrossRef

  43. 43
    Heiko Mix, Christina Weiler–Normann, Robert Thimme, Golo Ahlenstiel, Eui–Cheol Shin, Johannes Herkel, Chella S. David, Ansgar W. Lohse, Barbara Rehermann, Identification of CD4 T-Cell Epitopes in Soluble Liver Antigen/Liver Pancreas Autoantigen in Autoimmune Hepatitis, Gastroenterology, 2008, 135, 6, 2107

    CrossRef

  44. 44
    Teru Kumagi, Khalid Alswat, Gideon M. Hirschfield, Jenny Heathcote, New insights into autoimmune liver diseases, Hepatology Research, 2008, 38, 8
  45. 45
    R. Debbech, N. Maàmouri, S. Ajmi, M. -M. Azzouz, N. Ben Mami, M. H. Dougui, A. Filali, A. Ghorbel, F. Khedhiri, M. S. Krichene, T. Najjar, H. Saffar, B. Zouari, Particularités de l’hépatite auto-immune chez le sujet âgé en Tunisie. Résultats d’une étude multicentrique, Journal Africain d'Hépato-Gastroentérologie, 2008, 2, 4, 138

    CrossRef

  46. 46
    Albert J. Czaja, Performance parameters of the diagnostic scoring systems for autoimmune hepatitis, Hepatology, 2008, 48, 5
  47. 47
    Aldo J. Montano-Loza, Herschel A. Carpenter, Albert J. Czaja, Predictive Factors for Hepatocellular Carcinoma in Type 1 Autoimmune Hepatitis, The American Journal of Gastroenterology, 2008, 103, 8, 1944

    CrossRef

  48. 48
    Albert J. Czaja, Digestive Involvement in Systemic Autoimmune Diseases, 2008,

    CrossRef

  49. 49
    Shuichi Yokosawa, Kaname Yoshizawa, Masao Ota, Yoshihiko Katsuyama, Shigeyuki Kawa, Tetsuya Ichijo, Takeji Umemura, Eiji Tanaka, Kendo Kiyosawa, A genomewide DNA microsatellite association study of Japanese patients with autoimmune hepatitis type 1, Hepatology, 2007, 45, 2
  50. 50
    A. C. Goldberg, P. L. Bittencourt, L. C. Oliveira, R. Ramasawmy, M. L. C. Marin, S. A. Palacios, J. Kalil, G. Porta, Autoimmune Hepatitis in Brazil: An Overview, Scandinavian Journal of Immunology, 2007, 66, 2-3
  51. 51
    Albert J Czaja, Autoimmune hepatitis. Part A: pathogenesis, Expert Review of Gastroenterology & Hepatology, 2007, 1, 1, 113

    CrossRef

  52. 52
    Albert J Czaja, Autoimmune hepatitis. Part B: diagnosis, Expert Review of Gastroenterology & Hepatology, 2007, 1, 1, 129

    CrossRef

  53. 53
    Albert J. Czaja, Corticosteroids or not in severe acute or fulminant autoimmune hepatitis: Therapeutic brinksmanship and the point beyond salvation, Liver Transplantation, 2007, 13, 7
  54. 54
    Aldo J Montano Loza, Albert J Czaja, Current therapy for autoimmune hepatitis, Nature Clinical Practice Gastroenterology & Hepatology, 2007, 4, 4, 202

    CrossRef

  55. 55
    Paolo Muratori, Albert J. Czaja, Luigi Muratori, Alessandro Granito, Marcello Guidi, Silvia Ferri, Umberto Volta, Wilma Mantovani, Georgios Pappas, Fabio Cassani, Marco Lenzi, Francesco B. Bianchi, Evidence of a Genetic Basis for the Different Geographic Occurrences of Liver/Kidney Microsomal Antibody Type 1 in Hepatitis C, Digestive Diseases and Sciences, 2007, 52, 1, 179

    CrossRef

  56. 56
    Aldo J. Montano-Loza, Herschel A. Carpenter, Albert J. Czaja, Features associated with treatment failure in type 1 autoimmune hepatitis and predictive value of the model of end-stage liver disease, Hepatology, 2007, 46, 4
  57. 57
    María del Pilar Fortes, Irma V. Machado, Gisselle Gil, Mercedes Fernández-Mestre, Lucy Dagher, Roberto V. León, Nicolás E. Bianco, Paolo Tassinari, Genetic contribution of major histocompatibility complex class II region to type 1 autoimmune hepatitis susceptibility in Venezuela, Liver International, 2007, 27, 10
  58. 58
    Takeji Umemura, Masao Ota, Kaname Yoshizawa, Yoshihiko Katsuyama, Tetsuya Ichijo, Eiji Tanaka, Shigeyuki Kawa, Kendo Kiyosawa, Lack of association between FCRL3 and FcγRII polymorphisms in Japanese type 1 autoimmune hepatitis, Clinical Immunology, 2007, 122, 3, 338

    CrossRef

  59. 59
    Lok-Beng Koay, Chi-Shu Sun, Sun-Lung Tsai, Ching-Yih Lin, Significant Association of HLA-DQ5 with Autoimmune Hepatitis in Taiwan, Journal of the Formosan Medical Association, 2007, 106, 12, 1063

    CrossRef

  60. 60
    Sumita Verma, Michael Torbenson, Paul J. Thuluvath, The impact of ethnicity on the natural history of autoimmune hepatitis, Hepatology, 2007, 46, 6
  61. 61
    Michael P. Manns, Arndt Vogel, Autoimmune hepatitis, from mechanisms to therapy, Hepatology, 2006, 43, S1
  62. 62
    Albert J. Czaja, Herschel A. Carpenter, S. Breanndan Moore, Clinical and HLA phenotypes of type 1 autoimmune hepatitis in North American patients outside DR3 and DR4, Liver International, 2006, 26, 5
  63. 63
    Aldo J. Montano-Loza, Herschel A. Carpenter, Albert J. Czaja, Clinical significance of HLA DRB1*03–DRB1*04 in type 1 autoimmune hepatitis, Liver International, 2006, 26, 10
  64. 64
    Michael A Heneghan, Thawab Al-Chalabi, Ian G McFarlane, Cost-effectiveness of pharmacotherapy for autoimmune hepatitis, Expert Opinion on Pharmacotherapy, 2006, 7, 2, 145

    CrossRef

  65. 65
    Albert J. Czaja, Herschel A. Carpenter, Distinctive clinical phenotype and treatment outcome of type 1 autoimmune hepatitis in the elderly, Hepatology, 2006, 43, 3
  66. 66
    Brian D. Juran, Konstantinos N. Lazaridis, Genomics and complex liver disease: Challenges and opportunities, Hepatology, 2006, 44, 6
  67. 67
    Albert J Czaja, The role of autoantibodies as diagnostic markers of autoimmune hepatitis, Expert Review of Clinical Immunology, 2006, 2, 1, 33

    CrossRef

  68. 68
    Lok-Beng Koay, Ching-Yih Lin, Sun-Lung Tsai, Chuan Lee, Ching-Nan Lin, Ming-Juen Sheu, Hsing-Tao Kuo, Chi-Shu Sun, Type 1 Autoimmune Hepatitis in Taiwan: Diagnosis Using the Revised Criteria of the International Autoimmune Hepatitis Group, Digestive Diseases and Sciences, 2006, 51, 11, 1978

    CrossRef

  69. 69
    R. D'Souza, P. Sinnott, M. J. Glynn, C. A. Sabin, G.R. Foster, An unusual form of autoimmune hepatitis in young Somalian men, Liver International, 2005, 25, 2
  70. 70
    PAUL GOW, MARK HATHAWAY, BRIDGET GUNSON, JOANNE HEWARD, DAVID MUTIMER, Association of fulminant non-A non-B hepatitis with homozygosity for HLA A1-B8-DR3, Journal of Gastroenterology and Hepatology, 2005, 20, 4
  71. 71
    R. Oettinger, A. Brunnberg, P. Gerner, P. Wintermeyer, A. Jenke, S. Wirth, Clinical features and biochemical data of Caucasian children at diagnosis of autoimmune hepatitis, Journal of Autoimmunity, 2005, 24, 1, 79

    CrossRef

  72. 72
    A. Granito, L. Muratori, G. Pappas, P. Muratori, S. Ferri, F. Cassani, M. Lenzi, F. B. Bianchi, Clinical features of type 1 autoimmune hepatitis in elderly Italian patients, Alimentary Pharmacology & Therapeutics, 2005, 21, 10
  73. 73
    Akira Hiraide, Fumio Imazeki, Osamu Yokosuka, Tatsuo Kanda, Hiroshige Kojima, Kenichi Fukai, Yoichi Suzuki, Akira Hata, Hiromitsu Saisho, Fas Polymorphisms Influence Susceptibility to Autoimmune Hepatitis, The American Journal of Gastroenterology, 2005, 100, 6, 1322

    CrossRef

  74. 74
    Kaname Yoshizawa, Masao Ota, Yoshihiko Katsuyama, Tetsuya Ichijo, Akihiro Matsumoto, Eiji Tanaka, Kendo Kiyosawa, Genetic analysis of the HLA region of Japanese patients with type 1 autoimmune hepatitis, Journal of Hepatology, 2005, 42, 4, 578

    CrossRef

  75. 75
    LIEYING FAN, XIAOQING TU, YE ZHU, LIN ZHOU, THOMAS PFEIFFER, RALPH FELTENS, WINFRIED STOECKER, RENQIAN ZHONG, Genetic association of vitamin D receptor polymorphisms with autoimmune hepatitis and primary biliary cirrhosis in the Chinese, Journal of Gastroenterology and Hepatology, 2005, 20, 2
  76. 76
    Darko Nozic, Jovan Dimitrijevic, Slavica Knezevic-Usaj, Occurrence of autoimmune chronic hepatitis in siblings, Vojnosanitetski pregled, 2005, 62, 7-8, 591

    CrossRef

  77. 77
    Jean-Charles Duclos-Vallée, Vincent Di Martino, Alain Cazier, Eric Ballot, Catherine Johanet, Ana Maria Yamamoto, Jean-François Emile, Catherine Guettier, Pierre Coutarel, Jean-François Cadranel, Remission with ursodeoxycholic acid of type 1 autoimmune hepatitis resistant to azathioprine and steroids, Gastroentérologie Clinique et Biologique, 2005, 29, 11, 1173

    CrossRef

  78. 78
    JOSE M. NIETO, SAMMY SAAB, Transplantation of the Liver, 2005,

    CrossRef

  79. 79
    F. Grünhage, U. Spengler, H.P. Fischer, T. Sauerbruch, Autoimmune Hepatitis – Sequel of a Relapsing Hepatitis A in a 75-Year-Old Woman, Digestion, 2004, 70, 3, 187

    CrossRef

  80. 80
    J.F. Lucena Ramrez, D. Moreno Ramrez-Crdenas, M.P. Civeira Murillo, Enfermedades hep?ticas de patogenia inmunol?gica, Medicine - Programa de Formaci?n M?dica Continuada Acreditado, 2004, 9, 9, 552

    CrossRef

  81. 81
    Albert J. Czaja, Herschel A. Carpenter, Progressive fibrosis during corticosteroid therapy of autoimmune hepatitis, Hepatology, 2004, 39, 6
  82. 82
    Ian R. Mackay, Systemic Lupus Erythematosus, 2004,

    CrossRef

  83. 83
    Sandro Vento, Francesca Cainelli, Infection and Autoimmunity, 2004,

    CrossRef

  84. 84
    Albert J. Czaja, Encyclopedia of Gastroenterology, 2004,

    CrossRef

  85. 85
    Paulo L. Bittencourt, Selma A Palacios, Eduardo L.R. Cancado, Gilda Porta, Flair J. Carrilho, Antonio A. Laudanna, Jorge Kalil, Anna C. Goldberg, Cytotoxic T lymphocyte antigen-4 gene polymorphisms do not confer susceptibility to autoimmune hepatitis types 1 and 2 in Brazil, The American Journal of Gastroenterology, 2003, 98, 7, 1616

    CrossRef

  86. 86
    JJ FELD, EJ HEATHCOTE, Epidemiology of autoimmune liver disease, Journal of Gastroenterology and Hepatology, 2003, 18, 10
  87. 87
    J. Medina, L. García-Buey, R. Moreno-Otero, Immunopathogenetic and therapeutic aspects of autoimmune hepatitis, Alimentary Pharmacology & Therapeutics, 2003, 17, 1
  88. 88
    DE-KAI QIU, XIONG MA, Relationship between human leukocyte antigen-DRB1 and autoimmune hepatitis type I in Chinese patients, Journal of Gastroenterology and Hepatology, 2003, 18, 1
  89. 89
    ARNDT VOGEL, HEINER WEDEMEYER, MICHAEL P MANNS, CHRISTIAN P STRASSBURG, Autoimmune hepatitis and overlap syndromes, Journal of Gastroenterology and Hepatology, 2002, 17,
  90. 90
    Albert J. Czaja, Enrico O. Souto, Paulo L. Bittencourt, Eduardo L.R. Cancado, Gilda Porta, Anna Carla Goldberg, Peter T. Donaldson, Clinical distinctions and pathogenic implications of type 1 autoimmune hepatitis in Brazil and the United States, Journal of Hepatology, 2002, 37, 3, 302

    CrossRef

  91. 91
    M.E.R. da Silva, G. Porta, A.C. Golberg, P.L. Bittencourt, R.T. Fukui, M.R.S. Correia, I.K. Miura, R.S. Pugliese, V.L. Baggio, E.L.R. Cançado, J. Kalil, R.F. Santos, D.M. Rochal, B.L. Wajchenberg, M.J.M. Ursich, A.L. Rosenbloom, Diabetes Mellitus-Related Autoantibodies in Childhood Autoimmune Hepatitis, Journal of Pediatric Endocrinology and Metabolism, 2002, 15, 6

    CrossRef

  92. 92
    John M Vierling, Patricia A Flores, Evolving new therapies of autoimmune hepatitis, Clinics in Liver Disease, 2002, 6, 3, 825

    CrossRef

  93. 93
    Peter T Donaldson, Albert J Czaja, Genetic effects on susceptibility, clinical expression, and treatment outcome of type 1 autoimmune hepatitis, Clinics in Liver Disease, 2002, 6, 3, 707

    CrossRef

  94. 94
    Kirsten Muri Boberg, Prevalence and epidemiology of autoimmune hepatitis, Clinics in Liver Disease, 2002, 6, 3, 635

    CrossRef

  95. 95
    Jacob Kogan, Rifat Safadi, Yaffa Ashur, Daniel Shouval, Yaron Ilan, Prognosis of Symptomatic Versus Asymptomatic Autoimmune Hepatitis, Journal of Clinical Gastroenterology, 2002, 35, 1, 75

    CrossRef

  96. 96
    Yasemin Kosar, Sabite Kacar, Nurgul Sasmaz, Perihan Oguz, Nesrin Turhan, Erkan Parlak, Michael A. Heneghan, Ian G. McFarlane, Type 1 Autoimmune Hepatitis in Turkish Patients, Journal of Clinical Gastroenterology, 2002, 35, 2, 185

    CrossRef

  97. 97
    Anna Carla Goldberg, Paulo L Bittencourt, Bruno Mougin, Eduardo L.R Cançado, Gilda Porta, Flair Carrilho, Jorge Kalil, Analysis of HLA haplotypes in autoimmune hepatitis type 1: identifying the major susceptibility locus, Human Immunology, 2001, 62, 2, 165

    CrossRef

  98. 98
    Paulo Lisboa Bittencourt, Selma Aliotti Palácios, Eduardo Luiz Rachid Cançado, Gilda Porta, Sandra Drigo, Flair José Carrilho, Antonio Atı́lio Laudanna, Jorge Kalil, Anna Carla Goldberg, Autoimmune hepatitis in Brazilian patients is not linked to tumor necrosis factor α polymorphisms at position −308, Journal of Hepatology, 2001, 35, 1, 24

    CrossRef

  99. 99
    Robert G. Gish, Andrew Mason, AUTOIMMUNE LIVER DISEASE, Clinics in Liver Disease, 2001, 5, 2, 287

    CrossRef

  100. 100
    Idriss Djilali-Saiah, Patrice Ouellette, Sophie Caillat-Zucman, Dominique Debray, Joaquin I Kohn, Fernando Alvarez, CTLA-4/CD 28 region polymorphisms in children from families with autoimmune hepatitis, Human Immunology, 2001, 62, 12, 1356

    CrossRef

  101. 101
    Jameela Abdullah Al-Khalidi, Albert J. Czaja, Current Concepts in the Diagnosis, Pathogenesis, and Treatment of Autoimmune Hepatitis, Mayo Clinic Proceedings, 2001, 76, 12, 1237

    CrossRef

  102. 102
    Kosh Agarwal, Albert J. Czaja, David E. Jones, Peter T. Donaldson, Cytotoxic T lymphocyte antigen-4 (CTLA-4) gene polymorphisms and susceptibility to type 1 autoimmune hepatitis, Hepatology, 2000, 31, 1
  103. 103
    Nizar N Zein, Ahmad S Abdulkarim, Russell H Wiesner, Kathleen S Egan, David H Persing, Prevalence of diabetes mellitus in patients with end-stage liver cirrhosis due to hepatitis C, alcohol, or cholestatic disease, Journal of Hepatology, 2000, 32, 2, 209

    CrossRef

  104. 104
    Albert J. Czaja, Sharon Cookson, Patrizia K. Constantini, Michael Clare, James A. Underhill, Peter T. Donaldson, Cytokine polymorphisms associated with clinical features and treatment outcome in type 1 autoimmune hepatitis, Gastroenterology, 1999, 117, 3, 645

    CrossRef

  105. 105
    Paulo L. Bittencourt, Anna C. Goldberg, Eduardo L.R. Cancado, Gilda Porta, Flair J. Carrilho, Alberto Q. Farias, Selma A. Palacios, Josely M. Chiarella, Clarice P. Abrantes-Lemos, Vera L. Baggio, Antonio A. Laudanna, Jorge Kalil, Genetic heterogeneity in susceptibility to autoimmune hepatitis types 1 and 2, The American Journal of Gastroenterology, 1999, 94, 7, 1906

    CrossRef

  106. 106
    Michael P. Manns, Elmar Jaeckel, Searching for the needle in the haystack: Another candidate needle in autoimmune hepatitis?, Gastroenterology, 1999, 117, 3, 728

    CrossRef

  107. You have free access to this content107
    Thomas E. Trouillot, Roshan Shrestha, Igal Kam, Michael Wachs, Gregory T. Everson, Successful withdrawal of prednisone after adult liver transplantation for autoimmune hepatitis, Liver Transplantation and Surgery, 1999, 5, 5
  108. You have free access to this content108
    Albert J. Czaja, The immunoreactive propensity of autoimmune hepatitis: Is it corticosteroid-dependent after liver transplantation?, Liver Transplantation and Surgery, 1999, 5, 5
  109. 109
    Albert J. Czaja, Ahmad S. Abdulkarim, Herschel A. Carpenter, Rogelio G. Perez, David H. Persing, Nizar N. Zein, GB Virus-C Infection in Type 1 Autoimmune Hepatitis, Mayo Clinic Proceedings, 1998, 73, 5, 412

    CrossRef

  110. 110
    Albert J. Czaja, Herschel A. Carpenter, Paula J. Santrach, S. Breanndan Moore, Host- and disease-specific factors affecting steatosis in chronic hepatitis C, Journal of Hepatology, 1998, 29, 2, 198

    CrossRef

  111. 111
    Gideon M. Hirschfield, E. Jenny Heathcote, Autoimmune Hepatitis and Overlap Syndromes,